Polymorphism in Genes Encoding Two Fatty Acid Binding Proteins Increases Risk of Ischemic Stroke in a Chinese Han Population

Overview

Journal Front Genet

Date 2023 Apr 24

PMID 37091779

Authors

Maolin Cao

Yifei Zhang

Dan Chen

Jiaju Zhong

Xiaoli Zhang

Ling Yang

Xue Li

Liang Fang

Beizhong Liu

Fang Gong

Chanjuan Zhou

Affiliations

Soon will be listed here.

Abstract

Dyslipidemia is an independent predictor of ischemic stroke (IS). Genetic variations in lipid-metabolism related genes may increase the risk of IS. Fatty acid-binding protein 1 (FABP1) and fatty acid-binding protein 2 (FABP2) are lipid chaperones responsible for lipid transport and metabolism. The present study aimed to determine the association between or and ischemic stroke. A total of 251 participants were recruited composed of 138 patients with ischemic stroke and 113 healthy subjects. DNA was extracted from peripheral blood samples. The rs2241883 polymorphism in and rs1799883 polymorphism in were genotyped using polymerase chain reaction-restriction fragment length polymorphism. Generalized multifactor dimensionality reduction (GMDR) was used to find out the interaction combinations between two SNPs and environmental factors. The GA genotype of FABP2 rs1799883 increased susceptibility to ischemic stroke under overdominant inheritance model ( = 0.042). After adjusting for the risk factors of IS, it was associated with a significantly higher risk of IS in the codominant inheritance model (adjust OR = 3.431, 95%CI = 1.060-11.103, = 0.04). The interactions of rs2241883 and rs1799883 were not associated with IS risk ( = 0.172). Moreover, interaction analysis of two genes (rs1799883 and rs2241883) and two environmental factors (smoking and alcohol consumption) was associated with an increased risk of IS ( = 0.011). The GA genotype of FABP2 rs1799883, interactions between rs1799883, rs2241883 and smoking and alcohol consumption were associated with IS risk in Chinese Han populations.

Citing Articles

Smad4 Deficiency in S100A4 Macrophages Enhances Colitis-associated Tumorigenesis by Promoting Macrophage Lipid Metabolism Augmented M2 Polarization.

Liu T, Zhang X, Yan X, Cheng L, Yan X, Zeng F Int J Biol Sci. 2024; 20(15):6114-6129.

PMID: 39664586 PMC: 11628331. DOI: 10.7150/ijbs.98529.

References

Wanby P, Palmquist P, Brudin L, Carlsson M . Genetic variation of the intestinal fatty acid-binding protein 2 gene in carotid atherosclerosis. Vasc Med. 2005; 10(2):103-8. DOI: 10.1191/1358863x05vm609oa. View

Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S . Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med. 2008; 21(6):801-8. View

Levy E, Menard D, Delvin E, Stan S, Mitchell G, Lambert M . The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem. 2001; 276(43):39679-84. DOI: 10.1074/jbc.M105713200. View

Liu Y, Wu G, Han L, Zhao K, Qu Y, Xu A . Association of the FABP2 Ala54Thr polymorphism with type 2 diabetes, obesity, and metabolic syndrome: a population-based case-control study and a systematic meta-analysis. Genet Mol Res. 2015; 14(1):1155-68. DOI: 10.4238/2015.February.6.19. View

Wanby P, Nilsson I, Brudin L, Nyhammar I, Gustafsson I, Carlsson M . Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism. Acta Neurol Scand. 2007; 115(2):90-6. DOI: 10.1111/j.1600-0404.2006.00764.x. View

Tian Y, Li H, Wang S, Yan J, Chen Z, Li Z . Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects. Lipids. 2015; 50(3):275-82. DOI: 10.1007/s11745-015-3990-3. View

Wang Y, Li Z, Gu H, Zhai Y, Zhou Q, Jiang Y . China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National.... Stroke Vasc Neurol. 2022; 7(5):415-450. PMC: 9614174. DOI: 10.1136/svn-2021-001374. View

Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D . 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021; 52(7):e364-e467. DOI: 10.1161/STR.0000000000000375. View

Albala C, Villarroel A, Santos J, Angel B, Lera L, Liberman C . FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract. 2007; 77(2):245-50. DOI: 10.1016/j.diabres.2006.12.006. View

10.

Chow Y, Teh L, Chyi L, Lim L, Yee C, Wei L . Lipid Metabolism Genes in Stroke Pathogenesis: The Atherosclerosis. Curr Pharm Des. 2020; 26(34):4261-4271. DOI: 10.2174/1381612826666200614180958. View

11.

Fisher E, Weikert C, Klapper M, Lindner I, Mohlig M, Spranger J . L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab. 2007; 91(3):278-84. DOI: 10.1016/j.ymgme.2007.03.002. View

12.

Abbas S, Raza S, Chandra A, Rizvi S, Ahmed F, Eba A . Association of ACE, FABP2 and GST genes polymorphism with essential hypertension risk among a North Indian population. Ann Hum Biol. 2014; 42(5):461-9. DOI: 10.3109/03014460.2014.968206. View

13.

Garces Da Silva M, Guarin Y, Carrero Y, Stekman H, Nunez Bello M, Hernandez C . Postprandial Hypertriglyceridemia Is Associated with the Variant 54 Threonine Gene. J Cardiovasc Dev Dis. 2018; 5(3). PMC: 6162774. DOI: 10.3390/jcdd5030047. View

14.

Valizadeh M, Aghasizadeh M, Nemati M, Hashemi M, Aghaee-Bakhtiari S, Zare-Feyzabadi R . The association between a Fatty Acid Binding Protein 1 (FABP1) gene polymorphism and serum lipid abnormalities in the MASHAD cohort study. Prostaglandins Leukot Essent Fatty Acids. 2021; 172:102324. DOI: 10.1016/j.plefa.2021.102324. View

15.

Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

16.

Brouillette C, Bosse Y, Perusse L, Gaudet D, Vohl M . Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet. 2004; 49(8):424-432. DOI: 10.1007/s10038-004-0171-2. View

17.

Wang X, Zhang L, Sun W, Pei L, Tian M, Liang J . Changes of Metabolites in Acute Ischemic Stroke and Its Subtypes. Front Neurosci. 2021; 14:580929. PMC: 7829509. DOI: 10.3389/fnins.2020.580929. View

18.

Kloska A, Malinowska M, Gabig-Ciminska M, Jakobkiewicz-Banecka J . Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke. Int J Mol Sci. 2020; 21(10). PMC: 7279232. DOI: 10.3390/ijms21103618. View

19.

Huang X, Zhou Y, Sun Y, Wang Q . Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism. Prog Lipid Res. 2022; 87:101178. DOI: 10.1016/j.plipres.2022.101178. View

20.

Hotamisligil G, Bernlohr D . Metabolic functions of FABPs--mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015; 11(10):592-605. PMC: 4578711. DOI: 10.1038/nrendo.2015.122. View